-
Something wrong with this record ?
Pilot Outreach Program in Remedis-The Promising Step toward HCV Elimination among People Who Inject Drugs
L. Krekulová, T. Damajka, Z. Krumphanslová, V. Řehák
Language English Country Switzerland
Document type Journal Article, Research Support, Non-U.S. Gov't
NLK
Free Medical Journals
from 2004
PubMed Central
from 2005
Europe PubMed Central
from 2005
ProQuest Central
from 2009-01-01
Open Access Digital Library
from 2004-01-01
Open Access Digital Library
from 2005-01-01
Medline Complete (EBSCOhost)
from 2008-12-01
Health & Medicine (ProQuest)
from 2009-01-01
Public Health Database (ProQuest)
from 2009-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2004
- MeSH
- Antiviral Agents therapeutic use MeSH
- Hepacivirus MeSH
- Hepatitis C * drug therapy epidemiology prevention & control MeSH
- Substance Abuse, Intravenous * epidemiology MeSH
- Humans MeSH
- Drug Users * MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
The global effort to eliminate HCV infection requires new approaches to accessing and testing the affected population in a setting with as low of a threshold as possible. The focus should be on socially marginalized people who inject drugs (PWIDs) and who are not willing or able to visit standard medical services. With this vision, we established an outreach service-a testing point in an ambulance in the park in front of the Main Railway Station of the capital city of Prague-to provide bloodborne disease testing and treatment. The service was available every week on Wednesday afternoon. Over the initial two years of our experience, 168 unique people were tested. Of them, 82 (49%) were diagnosed with chronic HCV infection and were eligible for treatment with antivirals. Of these, 24 (29%) initiated antiviral treatment over the study period, and 17 (71%) of these individuals achieved a documented sustained virological response. Offering medical services in PWIDs' neighborhoods helps overcome barriers and increase the chances that they will become patients and begin HCV treatment. The described outcomes appear promising for reaching the vision of linkage to the care of such a hard-to-reach population and can serve as a feasible model of care for further expansion.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23004874
- 003
- CZ-PrNML
- 005
- 20230425171754.0
- 007
- ta
- 008
- 230418s2022 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/ijerph20010501 $2 doi
- 035 __
- $a (PubMed)36612821
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Krekulová, Laura $u Remedis, s.r.o., Vladimírova 10, 140 00 Prague 4, Czech Republic $u 4th Department of Internal Medicine, First Faculty of Medicine, Charles University in Prague, Kateřinská 32, 128 00 Prague 2, Czech Republic $1 https://orcid.org/0000000237719663 $7 jn20000919542
- 245 10
- $a Pilot Outreach Program in Remedis-The Promising Step toward HCV Elimination among People Who Inject Drugs / $c L. Krekulová, T. Damajka, Z. Krumphanslová, V. Řehák
- 520 9_
- $a The global effort to eliminate HCV infection requires new approaches to accessing and testing the affected population in a setting with as low of a threshold as possible. The focus should be on socially marginalized people who inject drugs (PWIDs) and who are not willing or able to visit standard medical services. With this vision, we established an outreach service-a testing point in an ambulance in the park in front of the Main Railway Station of the capital city of Prague-to provide bloodborne disease testing and treatment. The service was available every week on Wednesday afternoon. Over the initial two years of our experience, 168 unique people were tested. Of them, 82 (49%) were diagnosed with chronic HCV infection and were eligible for treatment with antivirals. Of these, 24 (29%) initiated antiviral treatment over the study period, and 17 (71%) of these individuals achieved a documented sustained virological response. Offering medical services in PWIDs' neighborhoods helps overcome barriers and increase the chances that they will become patients and begin HCV treatment. The described outcomes appear promising for reaching the vision of linkage to the care of such a hard-to-reach population and can serve as a feasible model of care for further expansion.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a uživatelé drog $7 D055030
- 650 12
- $a intravenózní abúzus drog $x epidemiologie $7 D015819
- 650 12
- $a hepatitida C $x farmakoterapie $x epidemiologie $x prevence a kontrola $7 D006526
- 650 _2
- $a antivirové látky $x terapeutické užití $7 D000998
- 650 _2
- $a Hepacivirus $7 D016174
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Damajka, Tomáš $u Remedis, s.r.o., Vladimírova 10, 140 00 Prague 4, Czech Republic
- 700 1_
- $a Krumphanslová, Zuzana $u Remedis, s.r.o., Vladimírova 10, 140 00 Prague 4, Czech Republic
- 700 1_
- $a Řehák, Vratislav $u Remedis, s.r.o., Vladimírova 10, 140 00 Prague 4, Czech Republic
- 773 0_
- $w MED00176090 $t International journal of environmental research and public health $x 1660-4601 $g Roč. 20, č. 1 (2022)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/36612821 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230418 $b ABA008
- 991 __
- $a 20230425171751 $b ABA008
- 999 __
- $a ok $b bmc $g 1925145 $s 1191083
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2022 $b 20 $c 1 $e 20221228 $i 1660-4601 $m International journal of environmental research and public health $n Int. j. environ. res. public health $x MED00176090
- LZP __
- $a Pubmed-20230418